Hans Moebius
2022
In 2022, Hans Moebius earned a total compensation of $2.1M as Chief Medical Officer at Athira Pharma, a 6% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $147,920 |
|---|---|
| Option Awards | $1,450,891 |
| Salary | $430,000 |
| Other | $74,922 |
| Total | $2,103,733 |
Moebius received $1.5M in option awards, accounting for 69% of the total pay in 2022.
Moebius also received $147.9K in non-equity incentive plan, $430K in salary and $74.9K in other compensation.
Rankings
In 2022, Hans Moebius' compensation ranked 1,686th out of 5,753 executives tracked by ExecPay. In other words, Moebius earned more than 70.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,686 out of 5,753 | 71st |
Division Manufacturing | 881 out of 3,133 | 72nd |
Major group Chemicals And Allied Products | 353 out of 1,419 | 75th |
Industry group Drugs | 325 out of 1,320 | 75th |
Industry Biological Products, Except Diagnostic Substances | 81 out of 291 | 72nd |
Source: SEC filing on April 5, 2023.
Moebius' colleagues
We found two more compensation records of executives who worked with Hans Moebius at Athira Pharma in 2022.